Boston Scientific stock heads into the open after a 0.28% dip
Published on 09/14/2026 at 05:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Boston Scientific stock closed at USD 42.98 on the NYSE on September 11, 2026, down 0.28% from the prior session according to exchange data compiled by Yahoo Finance. The shares traded between an intraday low and high that kept the close within the recent 52-week range, and after-hours dealings on September 11, 2026 lifted the price to USD 43.21, pointing to a modest stabilization into today’s session.
September 11, 2026 in numbers
Boston Scientific Corp. (ISIN US10117L1017, NYSE: BSX) ended the September 11, 2026 session at USD 42.98 on its primary US listing, slipping 0.28% from the prior close per NYSE quote data. The same data showed an after-hours indication of USD 43.21 later on September 11, 2026, with the day’s trading range keeping the stock within its established 52-week band and confirming that the close sat comfortably above the recent 52-week low. In parallel, the broader US market backdrop remained relatively soft, with major indices posting fractional moves that framed Boston Scientific’s slight decline as a stock-specific adjustment rather than part of a broad selloff.
Session dynamics followed earlier volatility linked to operational disruptions from a cyberattack disclosure. As Yahoo Finance reported on September 13, 2026, Boston Scientific told investors that an August 25, 2026 cyberattack temporarily interrupted manufacturing and shipping, forcing the company to withdraw and reset its guidance, a move that had weighed on the shares earlier in the week. According to the same report, management emphasized that demand and device performance remained intact, with the adjustment focused on the near-term impact of the disruption rather than a change in underlying business trends. Against that backdrop, the 0.28% dip on September 11, 2026 came after a more pronounced selloff that had previously pushed the stock toward its 52-week low, marking a comparatively contained move as trading volume normalized.
Today’s catalysts around September 14, 2026
Today, September 14, 2026, Boston Scientific faces no scheduled quarterly earnings release or annual meeting in the major earnings calendars consulted for the week, leaving investors focused on how the company navigates the aftermath of the cyberattack and its revised guidance framework. As Yahoo Finance highlighted, management’s comments on stabilizing operations and on the pace at which manufacturing and logistics recover from the August 25, 2026 incident remain central to market expectations for the coming quarters. On the macro side, US healthcare stocks today are sensitive to broader moves in the major US indices and to any updates on policy or reimbursement that could influence device makers, so Boston Scientific’s share performance into the open is set against that wider sector and index context even as stock-specific news continues to play a key role.
